1 Min Read
May 10 (Reuters) - Novelion Therapeutics Inc:
* NOVELION THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* QUARTERLY NET LOSS PER SHARE $1.76 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.